Handling related publications reporting real-world evidence in network meta-analysis: a case study in multiple sclerosis

Marissa Betts*, Kyle Fahrbach, Binod Neupane, Mahmoud Slim, Maria Pia Sormani, Gary Cutter, Thomas P.A. Debray, Marvin Rock

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Aim: The presence of two or more publications that report on overlapping patient cohorts poses a challenge for quantitatively synthesizing real-world evidence (RWE) studies. Thus, we evaluated eight approaches for handling such related publications in network meta-analyses (NMA) of RWE studies. Methods: Bayesian NMAs were conducted to estimate the annualized relapse rate (ARR) of disease-modifying therapies in multiple sclerosis. The NMA explored the impact of hierarchically selecting one pivotal study from related publications versus including all of them while adjusting for correlations. Results: When selecting one pivotal study from related publications, the ARR ratios were mostly similar regardless of the pivotal study selected. When including all related publications, there were shifts in the point estimates and the statistical significance. Conclusion: An a priori hierarchy should guide the selection among related publications in NMAs of RWE. Sensitivity analyses modifying the hierarchy should be considered for networks with few or small studies.

Original languageEnglish
Article numbere220132
JournalJournal of Comparative Effectiveness Research
Volume12
Issue number8
DOIs
Publication statusPublished - 2023

Keywords

  • dimethyl fumarate
  • disease-modifying therapies
  • multiple sclerosis
  • network meta-analysis
  • real-world evidence

Fingerprint

Dive into the research topics of 'Handling related publications reporting real-world evidence in network meta-analysis: a case study in multiple sclerosis'. Together they form a unique fingerprint.

Cite this